Autologous Stem Cell Transplantation (Autologous Bone Marrow Transplantation)for Pediatric DLBCL (Diffuse Large B-Cell Lymphoma) at Sheba Medical Center- JCI accredited and Top-10 Hospitals 2026 by Newsweek
Apa yang termasuk di paket ini
Prosedur Medis
- Konsultasi dengan ahli hematologi
- Biopsi nodus limfa sentinel
- Konsultasi dengan onkohematolog
- Diagnosis komprehensif limfoma
- Tes darah limfoma
- Pungsi sumsum tulang dengan analisis sitogenetik
- Transplantasi sumsum tulang
- Transplantasi sumsum tulang autologus
- Transplantasi sumsum tulang alogenik dari donor tidak sedarah
- Transplantasi sumsum tulang allogenik dari donor terkait
- 3 kali makan per hari oleh ahli gizi
- layanan perawat 24 jam
- Elektrokardiogram (EKG)
- Tes darah
- Rontgen dada
- Tes Anti-HIV
- Tes Anti-HBC
- Uji Anti-HCVAb
- Ekokardiografi
- Hitung darah lengkap (CBC)
- Tes darah biokimia
- PET/CT
- Konsultasi dengan ahli imunologi
- Konsultasi dengan ahli jantung
- Konsultasi dengan dokter hematologi pediatrik
- Konsultasi dengan dokter anak
- Konsultasi dengan onkohematologis
- MRI Kepala
- Biopsi
- Hitung darah lengkap dengan penanda kanker dan proteinogram
Durasi
- 30 hari di rumah sakit
Akomodasi
Rawat Inap
Transportasi
Transfer bandara-klinik-bandara
Informasi tambahan
Autologous Stem Cell Transplantation (Autologous Bone Marrow Transplantation)for Pediatric DLBCL (Diffuse Large B-Cell Lymphoma) at Sheba Medical Center – Advanced, Personalized Transplant Care for Children At Sheba Medical Center, we understand that a diagnosis of DLBCL (Diffuse Large B-Cell Lymphoma) in a child or adolescent is a deeply emotional experience for the entire family. While many children with DLBCL (Diffuse Large B-Cell Lymphoma) respond successfully to standard treatments such as chemotherapy and radiotherapy, some cases require more advanced therapy. For children with relapsed, refractory, or high-risk disease, Autologous Stem Cell Transplantation (ASCT) is a highly effective and well-established treatment approach that can help achieve long-term remission. Our pediatric transplant program combines global expertise, advanced medical technology, and compassionate, family-centered care to support children and families throughout every stage of treatment and recovery. The Role of Autologous Stem Cell Transplantation in Pediatric DLBCL (Diffuse Large B-Cell Lymphoma) Autologous Stem Cell Transplantation uses the child’s own healthy stem cells to restore bone marrow function after intensive chemotherapy. This approach plays a central role in treating: Relapsed DLBCL (Diffuse Large B-Cell Lymphoma) When DLBCL (Diffuse Large B-Cell Lymphoma) returns after initial treatment, ASCT may help achieve deeper disease control and improve long-term outcomes. Refractory Disease For children whose lymphoma does not respond adequately to standard therapy, high-dose chemotherapy followed by stem cell rescue offers a more intensive and effective treatment strategy. High-Risk Disease In selected high-risk cases, ASCT may be recommended as consolidation therapy to strengthen treatment response and reduce the risk of recurrence. How the Treatment Works Stem Cell Collection Before high-dose chemotherapy begins, healthy stem cells are collected from the child’s bloodstream and safely preserved. High-Dose Chemotherapy Children then receive intensive chemotherapy designed to eliminate remaining lymphoma cells throughout the body. Stem Cell Rescue After chemotherapy, the child’s own stem cells are reinfused to restore bone marrow function and support immune system recovery. This process allows doctors to deliver highly effective treatment while helping the body rebuild healthy blood-forming cells. Donor Options – Always a Solution Available Although most children with DLBCL (Diffuse Large B-Cell Lymphoma) undergo autologous transplantation using their own stem cells, some complex cases may require an allogeneic (donor) transplant. If a donor-based approach is needed, Sheba Medical Center provides access to multiple donor options: Matched family donors, when available Matched unrelated donors through international registries Haploidentical (half-matched) family donors Cord blood transplantation Using advanced matching technologies and global donor access, our team works to ensure that every child can receive the most suitable transplant option, even when a family match is not available. Advanced Pediatric Transplant Care Children undergoing transplantation at Sheba are treated in dedicated pediatric transplant units designed specifically for young patients and their families. Care includes: Highly protected, child-friendly environments Advanced infection prevention systems Pediatric-specific chemotherapy and transplant protocols Continuous monitoring by experienced pediatric oncology and transplant teams Every aspect of care is adapted to the physical and emotional needs of children. Precision, Safety, and Support Sheba Medical Center utilizes advanced laboratory technology and highly specialized transplant protocols to optimize safety and treatment effectiveness. Our multidisciplinary teams provide comprehensive supportive care throughout every stage of transplantation and recovery. Clinical Expertise in Pediatric Hodgkin Lymphoma Sheba Medical Center is a leading center for pediatric hematologic malignancies, offering: Extensive experience in relapsed and refractory DLBCL (Diffuse Large B-Cell Lymphoma) Expertise in Autologous Stem Cell Transplantation High success rates with advanced transplant protocols Long-term follow-up focused on growth, development, and quality of life Our treatment strategies are continuously refined according to the latest international research and clinical advances. Care That Supports the Whole Family We recognize that treating a child means supporting the entire family. At Sheba, families are cared for by a multidisciplinary pediatric team including oncologists, transplant specialists, nurses, psychologists, social workers, and care coordinators. From diagnosis through recovery, families receive clear communication, emotional support, and continuous guidance every step of the way. Why Families Choose Sheba for Pediatric ASCT Leading center for pediatric transplantation in lymphoma Strong expertise in relapsed and refractory DLBCL (Diffuse Large B-Cell Lymphoma) Advanced autologous transplant protocols Ability to secure suitable donors when needed Safe, supportive, child-centered care environment Dedicated international patient coordination services A Message of Hope At Sheba Medical Center, we combine advanced medical science with compassionate pediatric care. Through innovative approaches like Autologous Stem Cell Transplantation, we strive to provide children with DLBCL (Diffuse Large B-Cell Lymphoma) the strongest possible chance for recovery, while supporting families with confidence, care, and hope throughout the entire journey.
Bantuan Bookimed 24/7
- Koordinator medis pribadi
- Pengaturan perjalanan medis — pemesanan tiket pesawat dan kamar hotel dengan harga mitra khusus
- Pendampingan pasien selama perjalanan medis
Harga program
Apa yang TIDAK termasuk di paket ini
Dokter
Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.
He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.
He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.
His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.
Bagaimana pelayanan kami?
Tentang klinik
Sheba Medical Center adalah salah satu rumah sakit terbaik di Israel dan di dunia. Majalah Newsweek International menempatkan Rumah Sakit Sheba di 10 besar rumah sakit dunia pada tahun 2020. Rumah sakit ini memiliki 1.990 spesialisasi dan lebih dari 1.500.000 pasien dari seluruh dunia mengunjungi Rumah Sakit Sheba untuk pengobatan setiap tahun.
Pembayaran & Reward
Anda tidak membayar layanan kami
Anda melakukan pembayaran langsung di klinik atau ke rekening resmi mereka.
Beberapa klinik mungkin meminta deposit sebagai bagian kebijakannya.
Bayar secara bertahap dengan opsi cicilan.
Dapatkan reward dengan mereferensikan teman ke Bookimed.